探索生物制药的大容量皮下注射：临床管线和已批准产品的系统回顾

IF 5.6 2区医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL

mAbs Pub Date : 2024-09-15 DOI:10.1080/19420862.2024.2402713

Philip Green, Andreas Schneider, Jakob Lange

引用次数: 0

摘要

皮下注射（SC）给药正在改变生物制药的给药方式，促进了各种医疗环境下的护理，包括家庭自我治疗。大容量单次皮下注射（SC）给药是一种新型的生物制药方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Navigating large-volume subcutaneous injections of biopharmaceuticals: a systematic review of clinical pipelines and approved products

Subcutaneous (SC) administration is transforming the delivery of biopharmaceuticals, facilitating care in a variety of healthcare settings, including home self-treatment. Large-volume single SC dos...

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

mAbs 工程技术-仪器仪表

CiteScore

10.70

自引率

11.30%

发文量

审稿时长

6-12 weeks

期刊介绍： mAbs is a multi-disciplinary journal dedicated to the art and science of antibody research and development. The journal has a strong scientific and medical focus, but also strives to serve a broader readership. The articles are thus of interest to scientists, clinical researchers, and physicians, as well as the wider mAb community, including our readers involved in technology transfer, legal issues, investment, strategic planning and the regulation of therapeutics.